Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Double Blind Phase	STARTED	Placebo Solution	357
Double Blind Phase	STARTED	Testosterone Solution	358
Double Blind Phase	Received Study Drug	Placebo Solution	356
Double Blind Phase	Received Study Drug	Testosterone Solution	354
Double Blind Phase	COMPLETED	Placebo Solution	294
Double Blind Phase	COMPLETED	Testosterone Solution	302
Double Blind Phase	NOT COMPLETED	Placebo Solution	63
Double Blind Phase	NOT COMPLETED	Testosterone Solution	56
OLE Phase	STARTED	Placebo Solution	275
OLE Phase	STARTED	Testosterone Solution	283
OLE Phase	COMPLETED	Placebo Solution	222
OLE Phase	COMPLETED	Testosterone Solution	227
OLE Phase	NOT COMPLETED	Placebo Solution	53
OLE Phase	NOT COMPLETED	Testosterone Solution	56

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01816295/flow